POST SORAFENIB SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: THE ROLE OF TUMOR PROGRESSION AND LIVER IMPAIRMENT

被引：0
|
作者：
Iavarone, M. [1 ]
Cabibbo, G. [2 ]
Biolato, M. [3 ]
Della Corte, C. [1 ]
Maida, M. [2 ]
Basso, M. [3 ]
Vavassori, S. [1 ]
Camma, C. [2 ]
Grieco, A. [3 ]
Craxi, A. [2 ]
Colombo, M. [1 ]
机构：
[1] Univ Milan, AM &A Migliavacca Ctr Liver Dis, Fdn IRCCS Ca Granda Maggiore Hosp, Div Gastroenterol 1, Milan, Italy
[2] Univ Palermo, Gastroenterol Sect, DIBIMIS, Policlin P Giaccone, Palermo, Italy
[3] UCSC Catholic Univ Rome, Dept Internal Med, Gemelli Hosp, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2014年 / 46卷
关键词：
D O I：
10.1016/j.dld.2014.01.082
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T-42
引用
收藏
页码：E35 / E36
页数：2
相关论文
共 50 条
  • [31] Sorafenib combined with transarterial chemoembolization prolongs survival of patients with advanced hepatocellular carcinoma
    Liu, Quanguo
    Dai, Yajie
    JOURNAL OF BUON, 2020, 25 (02): : 945 - 951
  • [32] IMPACT OF SARCOPENIA ON SURVIVAL OF PATIENTS AFFECTED BY ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
    Reggidori, N.
    Lani, L.
    Renzulli, M.
    Gramenzi, A.
    Iannone, G.
    Granito, A.
    Piscaglia, F.
    Golfieri, R.
    Trevisani, F.
    Biselli, M.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S151 - S151
  • [33] Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation
    de'Angelis, Nicola
    Landi, Filippo
    Nencioni, Marco
    Palen, Anais
    Lahat, Eylon
    Salloum, Chady
    Compagnon, Philippe
    Lim, Chetana
    Costentin, Charlotte
    Calderaro, Julien
    Luciani, Alain
    Feray, Cyrille
    Azoulay, Daniel
    PROGRESS IN TRANSPLANTATION, 2016, 26 (04) : 348 - 355
  • [34] Sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure
    Cheng, Tsung-Yi
    Lee, Pei-Chang
    Chen, Yi-Tzen
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E833 - E834
  • [35] Changes of cytokines in patients with liver cirrhosis and advanced hepatocellular carcinoma treated by sorafenib
    Nagai, Hidenari
    Kanekawa, Takenori
    Kobayashi, Kojiro
    Mukozu, Takanori
    Matsui, Daigo
    Matsui, Teppei
    Kanayama, Masahiro
    Wakui, Noritaka
    Momiyama, Kouichi
    Shinohara, Mie
    Ishii, Koji
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (02) : 223 - 229
  • [36] Changes of cytokines in patients with liver cirrhosis and advanced hepatocellular carcinoma treated by sorafenib
    Hidenari Nagai
    Takenori Kanekawa
    Kojiro Kobayashi
    Takanori Mukozu
    Daigo Matsui
    Teppei Matsui
    Masahiro Kanayama
    Noritaka Wakui
    Kouichi Momiyama
    Mie Shinohara
    Koji Ishii
    Yoshinori Igarashi
    Yasukiyo Sumino
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 223 - 229
  • [37] Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
    Gauthier, Angela
    Ho, Mitchell
    HEPATOLOGY RESEARCH, 2013, 43 (02) : 147 - 154
  • [38] PROGRESSION RATE PROFILE AND RELATIONSHIP WITH SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB BEYOND FIRST PROGRESSION
    Reig, M.
    Rimola, J.
    Forner, A.
    Darnell, A.
    Rodriguez-Lope, C.
    Llarch, N.
    Ayuso, C.
    Bruix, J.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S401 - S401
  • [39] Evaluation survival of patients with advanced hepatocellular carcinoma and liver transplantation
    Cid-Gomez, L
    Carrera, E
    Garcia-Gonzalez, M
    Barcena, R
    Plaza, G
    Oton, E
    Vicente, E
    Quijano, Y
    Garcia-Plaza, A
    JOURNAL OF HEPATOLOGY, 2004, 40 : 76 - 76
  • [40] REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Ponziani, F. R.
    Annichiarico, B. E.
    Siciliano, M.
    Barone, C.
    Basso, M.
    Cesario, V.
    Campanale, M.
    Caracciolo, G.
    Garcovich, M.
    Zocco, M.
    Gigante, G.
    Rinninella, E.
    Sarno, G.
    Di Rienzo, T. A.
    D'Aversa, F.
    Gasbarrini, G.
    Gasbarrini, A.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S65 - S66
12345